Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Sunrise New Energy | EPOW | Oct 31, 2024 | 0.97 | +3.19 |
Sunrise Realty Trust | SUNS | Oct 31, 2024 | 13.72 | -2.21 |
Sunrun | RUN | Oct 31, 2024 | 14.45 | +2.56 |
Sunshine Biopharma | SBFM | Oct 31, 2024 | 2.82 | -1.05 |
Sunstone Hotel Investors H Pref | SHO-H | Oct 31, 2024 | 23.00 | -0.65 |
Sunstone Hotel Investors I Pref | SHO-I | Oct 31, 2024 | 21.72 | +0.56 |
Sunstone Hotel Investors Sunstone Hotel Investors | SHO | Oct 31, 2024 | 10.09 | -2.42 |
Super Group | SGHC | Oct 31, 2024 | 4.10 | -1.20 |
Super Hi International Holding ADR | HDL | Oct 31, 2024 | 16.31 | -0.91 |
Super League Enterprise | SLE | Oct 31, 2024 | 1.02 | +0.49 |
Super Micro Computer | SMCI | Oct 31, 2024 | 29.11 | -11.97 |
Supercom | SPCB | Oct 31, 2024 | 3.19 | -6.45 |
Superior Group of Companies | SGC | Oct 31, 2024 | 14.75 | -2.64 |
Superior Industries International | SUP | Oct 31, 2024 | 2.76 | +0.73 |
Supernus Pharmaceuticals | SUPN | Oct 31, 2024 | 34.07 | -2.29 |
Surf Air Mobility | SRFM | Oct 31, 2024 | 1.77 | -7.33 |
SurgePays | SURG | Oct 31, 2024 | 1.67 | +8.79 |
Surgery Partners | SGRY | Oct 31, 2024 | 28.80 | -2.07 |
Surmodics | SRDX | Oct 31, 2024 | 37.52 | +0.05 |
Suro Capital | SSSS | Oct 31, 2024 | 4.60 | -0.86 |
Surrozen | SRZN | Oct 31, 2024 | 13.44 | +21.21 |
Sutro Biopharma | STRO | Oct 31, 2024 | 3.25 | -8.71 |
Suzano ADR | SUZ | Oct 31, 2024 | 10.27 | -1.53 |
Sweden Index MSCI Ishares | EWD | Oct 31, 2024 | 39.92 | -0.97 |
Sweetgreen | SG | Oct 31, 2024 | 36.10 | -3.68 |
Swiftmerge Acquisition A | IVCP | Oct 31, 2024 | 11.06 | 0.00 |
Swiftmerge Acquisition Unit | IVCPU | Oct 31, 2024 | 11.30 | 0.00 |
Swiss Franc Trust | FXF | Oct 31, 2024 | 102.91 | +0.31 |
Swiss Helvetia Fund | SWZ | Oct 31, 2024 | 8.11 | -0.98 |
Switzerland Alphadex First Trust | FSZ | Oct 31, 2024 | 66.64 | -1.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.